Niraku GC Holdings, Inc.
1245.HK News Today: Stay Updated with the Latest Niraku GC Holdings, Inc. News in Real Time
Find 1245.HK news now at Meyka AI. Stay informed with the latest Niraku GC Holdings, Inc. stocks updates, including price news, market analysis, and expert insights.

Powerica share price lists at 7% discount on NSE; investors incur losses per lot
We at Market Insights Today begin with breaking news: Powericaβs share price made a muted debut on the National Stock Exchange (NSE) on April 2, 2026. Instead of listing above the IPO price, the stock opened at a discount of around 7% compared with its issue price. This unexpected move created immediate losses for someβ¦

Jefferies Maintains Hold on LULU (Lululemon Athletica Inc.) March 2026
Jefferies maintains Hold on LULU; we review the March 17, 2026 analyst view and investor implications for LULU analyst rating

Jefferies Holds, RBC Keeps Outperform on The Trade Desk (TTD) March 2026
TTD analyst rating update: Jefferies holds at Hold and RBC stays Outperform in March 2026

1690.HK Lap Kei Engineering HKSE up 44.27% intraday (02 Apr 2026): heavy volume drives momentum
Intraday note on 1690.HK stock: Lap Kei Engineering jumps 44.27% to HK$0.189 on volume 12,850,000 in Hong Kong

RBC Downgrades Starbucks (SBUX) to Sector Perform March 2026
RBC downgrades Starbucks: SBUX analyst rating falls to Sector Perform on March 17, 2026

TMD.TO Titan Medical TSX at C$1.12 pre-market 02 Apr 2026: volume spike
TMD.TO stock jumps to C$1.12 pre-market on heavy volume; trading signals volatile interest and analyst-grade outlook

UBS Maintains Buy on Planet Fitness (PLNT) March 2026
UBS maintained Buy and cut PT to $120; PLNT analyst rating stayed Buy on March 18, 2026

BMO Maintains Market Perform on HealthEquity (HQY) March 2026
HQY analyst rating update: BMO maintains Market Perform for HealthEquity on March 18, 2026 with Meyka grade A

April 02: Moon Landing 1969 Trend Spikes on Satire, Misinformation Risk
GB searches for βmoon landing 1969β jumped 200% after satire and claims went viral. We map misinformation risk, UK legal exposure, and ad-safety impacts for investors.